Improvement in Parkinson Disease Symptoms After Treatment for COVID-19 with Monoclonal Antibodies
Description
BACKGROUND: Parkinson disease (PD) is a neurodegenerative disease characterized by motor symptoms, such as bradykinesia, and non-motor symptoms, such as fatigue, which can be a particularly disabling feature of the disease.